KELOWNA, British Columbia, Oct. 3, 2017 /PRNewswire/ -- Marapharm Ventures Inc. ("Marapharm" or the "Company") (OTCQB: MRPHF) (CSE: MDM) (FSE: 2M0) "Marapharm" announces that the British Columbia Corporate Registry has approved the request to hold the annual AGM (Annual General Meeting) in Las Vegas, Nevada, November 17, 2017.
Marapharm announced August 10, 2017, that it is locating administration and executives to Las Vegas, Nevada to be proximate to the company's rapidly expanding base of operations in the United States.
About Marapharm Ventures Inc.
Marapharm is a publicly traded company primarily investing in the medical and recreational cannabis space, with corporate operations based in British Columbia, Canada. Since 2016 they have rapidly expanded their footprint to include production locations in the key North American states of Washington, Nevada, and California. They actively seek expansion opportunities worldwide.
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQB, and in Europe, ticker symbol 2Mo on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQB® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQB® accepts responsibility for the adequacy or accuracy of this release.
Certain statements contained in this news release constitute forward looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", 'may", "will", "project", "should", 'believe", and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.
For Further Information:
SOURCE Marapharm Ventures Inc.